Inicio>>Signaling Pathways>> Membrane Transporter/Ion Channel>> Potassium Channel>>Ropivacaine mesylate

Ropivacaine mesylate

Catalog No.GC39843

El mesilato de ropivacaÍna es un agente anestésico local de amida de acciÓn prolongada para un bloqueo espinal y bloquea eficazmente el dolor neuropÁtico.

Products are for research use only. Not for human use. We do not sell to patients.

Ropivacaine mesylate Chemical Structure

Cas No.: 854056-07-8

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL Water)
39,00 $
Disponible
10mg
32,00 $
Disponible
50mg
57,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Ropivacaine mesylate is an aminoamide compound, effectively blocks neuropathic pain. Ropivacaine mesylate is an inhibitor of K2P (two-pore domain potassium channel) TREK-1 with an IC50 of 402.7 μM in COS-7 cell's membrane. Ropivacaine mesylate inhibits pressure-induces lung endothelial hyperpermeability in models of acute hypertension[1][2].

[1]. Li TF, et al. Epidural sustained release ropivacaine prolongs anti-allodynia and anti-hyperalgesia in developing and established neuropathic pain. PLoS One. 2015 Jan 24;10(1):e0117321. [2]. Milan Patel, et al. Ropivacaine Inhibits Pressure-Induced Lung Endothelial Hyperpermeability in Models of Acute Hypertension. Life Sci. 2019 Apr 1;222:22-28.

Reseñas

Review for Ropivacaine mesylate

Average Rating: 5 ★★★★★ (Based on Reviews and 37 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ropivacaine mesylate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.